French Office REITs Stock News

Alstom (ENXTPA:ALO) just secured a milestone contract, agreeing to deliver 42 Coradia Max double-deck electric trains and 30 years of comprehensive maintenance to PKP Intercity. This deal marks a major boost for the company’s position in Poland and reinforces its long-term service portfolio. See our latest analysis for Alstom. Investors have warmed up to Alstom lately, with news of its Polish mega-contract sparking a notable shift in sentiment. The stock is up over 8% in the past week alone...

On October 31, 2025, OVH Groupe S.A. was removed from the Euronext 150 Index, impacting its standing among major publicly traded companies in Europe. This removal can prompt institutional investors and index-tracking funds to adjust their holdings, often influencing trading volumes and investor perception. We’ll explore how OVH Groupe’s removal from the Euronext 150 Index could affect its broader investment narrative and institutional appeal. These 13 companies survived and thrived after...

On October 30, 2025, ERAMET S.A. announced an updated production outlook, lowering its 2025 manganese ore transported volume guidance to between 6.1 and 6.3 million tonnes, down from the previous estimate of 6.5 to 7.0 million tonnes, while leaving guidance for nickel ore, lithium carbonate, and mineral sands unchanged. This revision highlights that ERAMET anticipates challenges specific to manganese operations, even as its forecasts for other commodities remain stable. We'll examine what...

Voltalia (ENXTPA:VLTSA) shares have shown some interesting moves recently, catching the attention of investors curious about the utility sector. The past month saw the stock slipping. However, there are a few key trends to consider. See our latest analysis for Voltalia. Looking beyond this month's slide, Voltalia has struggled to hold momentum, with a 1-year total shareholder return of -4.3% and a three-year total return of -56%. Despite a few positive days, the longer-term trend suggests...

In recent days, BNP Paribas announced several senior leadership appointments in the UK and Middle East, while also deploying generative AI to enhance ESG reporting efficiency across its operations. This combination of executive expansion and technology integration signals a concerted push to grow BNP Paribas's presence in priority markets and streamline its services for institutional clients. We'll examine how the strengthening of BNP Paribas's alternative investments leadership supports...

SPIE (ENXTPA:SPIE) just wrapped up its Q3 2025 earnings call and issued updated guidance for the year. The company signaled that revenue will exceed €10 billion, boosted by further organic growth and active bolt-on acquisitions. See our latest analysis for SPIE. SPIE’s upbeat Q3 and forward-looking guidance have kept the spotlight on the stock, even as the share price pulled back 7.7% over the last month and nearly 19% in the most recent quarter. Despite these short-term swings, SPIE boasts a...

Teleperformance (ENXTPA:TEP) has revised its earnings guidance for 2025, now projecting group like-for-like revenue growth between 1% and 2% for the year. This is a change from its earlier range of 2% to 4%. This update is drawing attention from investors as expectations for growth are recalibrated. See our latest analysis for Teleperformance. The lowered revenue guidance has weighed on Teleperformance’s momentum, with the stock’s 1-year total shareholder return sitting at -30.35% and a...

The European market has recently experienced a pullback, with the pan-European STOXX Europe 600 Index ending 1.24% lower amid concerns about overvaluation in artificial intelligence-related stocks. Despite these challenges, the search for promising investment opportunities continues, particularly among smaller companies that might not be on every investor's radar. While the term "penny stocks" may seem outdated, these smaller or newer companies can still offer significant growth potential...

JCDecaux SE recently announced its third quarter 2025 sales, reporting €926.1 million in revenue, compared to €948.2 million during the same period last year, and €2.79 billion for the first nine months of 2025. This sales update gives investors a detailed view of recent operational performance, highlighting trends in the company's revenue momentum throughout the year. We'll explore how the recent quarterly sales figures may influence JCDecaux's future revenue expectations and core...

Société Générale Société anonyme (ENXTPA:GLE) just posted its third-quarter and nine-month earnings, and what stands out is a clear jump in net income compared to last year. This performance is getting investor attention for good reason. See our latest analysis for Société Générale Société anonyme. After posting stronger profits, Société Générale Société anonyme’s share price has surged, notching a 1-month share price return of nearly 9 percent and more than doubling year-to-date. Momentum is...

In recent developments, Orano and Capgemini announced the deployment of Hoxo, the first AI-powered humanoid robot in the nuclear sector, while Capgemini also expanded its partnership with Siemens to co-develop AI-native digital solutions for engineering and manufacturing. These advances highlight Capgemini’s move to embed advanced AI into critical infrastructure and industrial processes, reinforcing its position as a key technology enabler across regulated and innovative sectors. We'll...

Ayvens (ENXTPA:AYV) sparked market attention after announcing a special interim dividend of EUR 0.42 per share. This represents a significant one-off payout pending shareholder approval. The company also reported a board member’s resignation. See our latest analysis for Ayvens. Ayvens has been powering ahead, with its 1-year total shareholder return of 77.05% far outpacing the share price’s already impressive 68.65% year-to-date climb. The jump in recent months appears to be driven by upbeat...

The Valeo SE ( EPA:FR ) share price has done very well over the last month, posting an excellent gain of 26%. Looking...

The European market has recently experienced a pullback, with concerns over artificial intelligence-related stock valuations affecting investor sentiment across major indices. Despite these challenges, penny stocks remain an intriguing area for investors seeking growth opportunities at lower price points. Often associated with smaller or newer companies, penny stocks can still offer significant potential when backed by strong financial health and solid fundamentals.

The ISPD Network, S.A. ( EPA:ALISP ) share price has fared very poorly over the last month, falling by a substantial...

When close to half the companies in France have price-to-earnings ratios (or "P/E's") above 17x, you may consider...

Key Insights Cerinnov Group's estimated fair value is €0.24 based on 2 Stage Free Cash Flow to Equity With €0.25 share...

On October 31, Nanobiotix announced it had entered a royalty-based financing agreement with HealthCare Royalty to secure up to US$71 million in non-dilutive capital, supporting its operations and the advancement of nanotherapeutic platforms. This agreement signals a reinforced financial position for Nanobiotix, potentially underpinning its ability to sustain research and development initiatives over the long term. We’ll explore how this infusion of non-dilutive capital from the royalty-based...

Eiffage announced that its concessions division has signed a EUR171 million DBFM contract with the Belgian Building Authority and Federal Public Justice Service to deliver, operate, and maintain a new 39,000 m2 prison facility in Wallonia, Belgium, supported by a consortium of subsidiaries and specialist partners. This long-term project marks Eiffage's second major prison contract in Belgium, demonstrating the company's ability to secure repeat high-value infrastructure opportunities in...

Compagnie de Saint-Gobain (ENXTPA:SGO) just released its sales figures for the third quarter and the first nine months of 2025. Investors are digesting fresh data to weigh what it means for the company’s valuation. See our latest analysis for Compagnie de Saint-Gobain. Saint-Gobain’s share price has dipped 6.9% over the past month, reflecting investors’ cautious response to the latest sales update, even as long-term trends remain impressive. Over the last three years, total shareholder return...

Oxford Nanopore Technologies and bioMérieux recently launched AmPORE-TB, a Research Use Only solution for rapid detection of antimicrobial resistance mutations in tuberculosis, with recognition from the World Health Organization and a focus on high-need, low- and middle-income regions. This development highlights bioMérieux’s expanding role in addressing global health threats and reflects continued innovation in molecular diagnostics through international partnerships. Let’s explore how the...

Société BIC (ENXTPA:BB) just made its debut in the Euronext 150 Index, a move that often attracts attention from institutional investors and funds that track the index’s performance. See our latest analysis for Société BIC. After a challenging period, Société BIC's recent addition to the Euronext 150 has sparked some renewed interest despite a 24% year-to-date decline in share price and a 1-year total shareholder return of -21.7%. While short-term momentum remains subdued, the company's...

Edenred (ENXTPA:EDEN) has just unveiled a fresh partnership with WonderDays, utilizing its payment solutions expertise to support and scale WonderDays’ gift card platform. This move could help extend Edenred’s reach within B2B, B2C, and the employee rewards markets. See our latest analysis for Edenred. Edenred’s headline partnership comes during a tough stretch for the stock, with a 1-year total shareholder return of -24.4% and the share price sliding 34.7% year-to-date. Short-term pressures...

Recently, Ipsen presented late-breaking data from the ELATIVE trial at the AASLD Liver Meeting 2025 in Washington, revealing that IQIRVO® showed sustained biochemical response, stabilization of fibrosis markers, and notable symptom improvements over more than three years in primary biliary cholangitis patients. Further analysis indicated that IQIRVO may influence fatigue-related mitochondrial pathways, suggesting the treatment's potential long-term impact on disease progression and patient...